Correlation Between LianBio ADR and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both LianBio ADR and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LianBio ADR and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LianBio ADR and Verrica Pharmaceuticals, you can compare the effects of market volatilities on LianBio ADR and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LianBio ADR with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of LianBio ADR and Verrica Pharmaceuticals.
Diversification Opportunities for LianBio ADR and Verrica Pharmaceuticals
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between LianBio and Verrica is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding LianBio ADR and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and LianBio ADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LianBio ADR are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of LianBio ADR i.e., LianBio ADR and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between LianBio ADR and Verrica Pharmaceuticals
Given the investment horizon of 90 days LianBio ADR is expected to under-perform the Verrica Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, LianBio ADR is 2.36 times less risky than Verrica Pharmaceuticals. The stock trades about -0.12 of its potential returns per unit of risk. The Verrica Pharmaceuticals is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 583.00 in Verrica Pharmaceuticals on August 27, 2024 and sell it today you would lose (483.00) from holding Verrica Pharmaceuticals or give up 82.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 9.38% |
| Values | Daily Returns |
LianBio ADR vs. Verrica Pharmaceuticals
Performance |
| Timeline |
| LianBio ADR |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Verrica Pharmaceuticals |
LianBio ADR and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LianBio ADR and Verrica Pharmaceuticals
The main advantage of trading using opposite LianBio ADR and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LianBio ADR position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.| LianBio ADR vs. Sensei Biotherapeutics | LianBio ADR vs. NextCure | LianBio ADR vs. Nuvation Bio | LianBio ADR vs. Inozyme Pharma |
| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |